微生态制剂临床使用的调查分析

A research and analysis on the clinical application of microecological modulators

目的:了解我院微生态制剂的应用情况。方法:抽取我院2006年1月份、4月份、8月份门诊处方11459张,其中应用微生态制剂处方693张;分析微生态制剂使用情况,与抗生素、某些消化系统用药联合应用情况及微生态制剂之间的联用情况,就算用药的合理性进行分析。结果:含微生态制剂处方占被抽取处方数的6.05%,以双歧杆菌-嗜热乳杆菌-肠球菌三联活菌散剂(培菲康)使用率最高,占40.12%;微生态制剂与抗生素联用率为44.15%;两种微生态制剂合用率为0.72%,无两种以上微生态制剂合用。结论:我院在微生态制剂使用过程中存在一些不合理现象,应该引起医师和药师的共同关注。

Objective：To study the application of microecological modulators in our hospital. Methods： 11 459 pieces of prescription were picked out from the months of January, April and August, 2006, in our hospital. Among them, there were 693 pieces of microecological modulator prescription. The application of microecological modulators was studied and also their combined application with antibiotics and with medicaments for alimentary system disorder, and then its rationality was analyzed. Results： The prescriptions of, or including microecological modulators took 6.05% of all the prescriptions chosen, with Live Combined Bifidobacterium, Lactobacillus and Enterococcus Powder （Bifico） at the top, taking up to 40.12 %. The combined application with antibiotics was 44.15%, and the combined application of two microecological modulators was 0.72%, and no combined application of more than two microeeological modulators were found. Conclusions： There are some unreasonable applications of micreecological modulators in our hospital, to which a special attention must be paid by both physicians and pharmacists.